Cytokinetics, Incorporated (CYTK) compared with its closest peers (NRIX, ARCT, ETON, CTMX, LFCR). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Nurix Therapeutics, Arcturus Therapeutics, Eton Pharmaceuticals, CytomX Therapeutics, Lifecore Biomedical, Zevra Therapeutics, Viridian Therapeutics, UroGen Pharma, Rockwell Medical and Gyre Therapeutics share Cytokinetics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Nurix Therapeutics, Inc. (NRIX) | $2.77B | -5.8 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $382.29M | -2.5 |
| Eton Pharmaceuticals, Inc. (ETON) | $1.81B | 142.9 |
| CytomX Therapeutics, Inc. (CTMX) | $714.71M | -28.5 |
| Lifecore Biomedical, Inc. (LFCR) | $172.61M | -15.2 |
| Zevra Therapeutics, Inc. (ZVRA) | $701.40M | 6.4 |
| Viridian Therapeutics, Inc. (VRDN) | $2.50B | — |
| UroGen Pharma Ltd. (URGN) | $2.28B | -7.3 |
| Rockwell Medical, Inc. (RMTI) | $315.76M | — |
| Gyre Therapeutics, Inc. (GYRE) | $768.30M | 352.0 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
CYTK overview · CYTK earnings · CYTK financials · CYTK KPIs · CYTK documents · CYTK ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.